Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2009 1
2011 1
2012 4
2013 4
2014 4
2015 3
2016 3
2017 4
2018 6
2019 6
2020 4
2021 3
2022 4
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Design and Synthesis of Novel Amino and Acetamidoaurones with Antimicrobial Activities.
Di Maio A, Olleik H, Courvoisier-Dezord E, Guillier S, Neulat-Ripoll F, Haudecoeur R, Bolla JM, Casanova M, Cavalier JF, Canaan S, Pique V, Charmasson Y, Baydoun E, Hijazi A, Perrier J, Maresca M, Robin M. Di Maio A, et al. Among authors: cavalier jf. Antibiotics (Basel). 2024 Mar 26;13(4):300. doi: 10.3390/antibiotics13040300. Antibiotics (Basel). 2024. PMID: 38666976 Free PMC article.
Evaluation of the Efficiency of Random and Diblock Methacrylate-Based Amphiphilic Cationic Polymers against Major Bacterial Pathogens Associated with Cystic Fibrosis.
Casanova M, Olleik H, Hdiouech S, Roblin C, Cavalier JF, Point V, Jeannot K, Caron B, Perrier J, Charriau S, Lafond M, Guillaneuf Y, Canaan S, Lefay C, Maresca M. Casanova M, et al. Among authors: cavalier jf. Antibiotics (Basel). 2023 Jan 8;12(1):120. doi: 10.3390/antibiotics12010120. Antibiotics (Basel). 2023. PMID: 36671321 Free PMC article.
Synthesis and Biological Characterization of Fluorescent Cyclipostins and Cyclophostin Analogues: New Insights for the Diagnosis of Mycobacterial-Related Diseases.
Sarrazin M, Martin BP, Avellan R, Gnawali GR, Poncin I, Le Guenno H, Spilling CD, Cavalier JF, Canaan S. Sarrazin M, et al. Among authors: cavalier jf. ACS Infect Dis. 2022 Dec 9;8(12):2564-2578. doi: 10.1021/acsinfecdis.2c00448. Epub 2022 Nov 15. ACS Infect Dis. 2022. PMID: 36379042 Free article.
Direct capture, inhibition and crystal structure of HsaD (Rv3569c) from M. tuberculosis.
Barelier S, Avellan R, Gnawali GR, Fourquet P, Roig-Zamboni V, Poncin I, Point V, Bourne Y, Audebert S, Camoin L, Spilling CD, Canaan S, Cavalier JF, Sulzenbacher G. Barelier S, et al. Among authors: cavalier jf. FEBS J. 2023 Mar;290(6):1563-1582. doi: 10.1111/febs.16645. Epub 2022 Oct 13. FEBS J. 2023. PMID: 36197115 Free article.
Identification of cell wall synthesis inhibitors active against Mycobacterium tuberculosis by competitive activity-based protein profiling.
Li M, Patel HV, Cognetta AB 3rd, Smith TC 2nd, Mallick I, Cavalier JF, Previti ML, Canaan S, Aldridge BB, Cravatt BF, Seeliger JC. Li M, et al. Among authors: cavalier jf. Cell Chem Biol. 2022 May 19;29(5):883-896.e5. doi: 10.1016/j.chembiol.2021.09.002. Epub 2021 Oct 1. Cell Chem Biol. 2022. PMID: 34599873 Free PMC article.
44 results